Weltermann A - Search Results

1

Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism.

Eichinger S, Weltermann A, Minar E, Stain M, Schönauer V, Schneider B, Kyrle PA. Eichinger S, et al. Among authors: weltermann a. Arch Intern Med. 2004 Jan 12;164(1):92-6. doi: 10.1001/archinte.164.1.92. Arch Intern Med. 2004. PMID: 14718328

2

Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.

Wolzt M, Weltermann A, Nieszpaur-Los M, Schneider B, Fassolt A, Lechner K, Eichler HG, Kyrle PA. Wolzt M, et al. Among authors: weltermann a. Thromb Haemost. 1995 Mar;73(3):439-43. Thromb Haemost. 1995. PMID: 7667826 Clinical Trial.

3

Laboratory studies on the reliability of a commercial immunoassay for thrombin-antithrombin complexes.

Weltermann A, Kyrle PA. Weltermann A, et al. Blood Coagul Fibrinolysis. 1996 Jul;7(5):580-1. doi: 10.1097/00001721-199607000-00011. Blood Coagul Fibrinolysis. 1996. PMID: 8874870 No abstract available.

4

Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment.

Kyrle PA, Brockmeier J, Weltermann A, Eichinger S, Speiser W, Lechner K, Eichler HG. Kyrle PA, et al. Among authors: weltermann a. Thromb Haemost. 1997 Apr;77(4):685-9. Thromb Haemost. 1997. PMID: 9134643 Clinical Trial.

5

Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism.

Kyrle PA, Eichinger S, Pabinger I, Stümpflen A, Hirschl M, Bialonczyk C, Schneider B, Mannhalter C, Melichart M, Traxler G, Weltermann A, Speiser W, Lechner K. Kyrle PA, et al. Among authors: weltermann a. Thromb Haemost. 1997 May;77(5):829-33. Thromb Haemost. 1997. PMID: 9184387

6

Comparison of the effects of different low molecular weight heparins on the hemostatic system activation in vivo in man.

Wolzt M, Eder M, Weltermann A, Entlicher J, Eichler HG, Kyrle PA. Wolzt M, et al. Among authors: weltermann a. Thromb Haemost. 1997 Aug;78(2):876-9. Thromb Haemost. 1997. PMID: 9268188 Clinical Trial.

7

Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.

Kyrle PA, Stümpflen A, Hirschl M, Bialonczyk C, Herkner K, Speiser W, Weltermann A, Kaider A, Pabinger I, Lechner K, Eichinger S. Kyrle PA, et al. Among authors: weltermann a. Thromb Haemost. 1997 Nov;78(5):1327-31. Thromb Haemost. 1997. PMID: 9408013 Clinical Trial.

8

A novel immunoassay for the quantification of human tissue factor binding to activated factor VII.

Weltermann A, Eichinger S, Kyrle PA. Weltermann A, et al. Blood Coagul Fibrinolysis. 1998 Mar;9(2):177-82. doi: 10.1097/00001721-199803000-00009. Blood Coagul Fibrinolysis. 1998. PMID: 9622216

9

Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis.

Weltermann A, Pabinger I, Geissler K, Jäger U, Gisslinger H, Knöbl P, Eichinger S, Kyrle PA, Valent P, Speiser W, Schwarzinger I, Mannhalter C, Lechner K. Weltermann A, et al. Leukemia. 1998 Aug;12(8):1182-6. doi: 10.1038/sj.leu.2401101. Leukemia. 1998. PMID: 9697871

10

Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene.

Kyrle PA, Mannhalter C, Béguin S, Stümpflen A, Hirschl M, Weltermann A, Stain M, Brenner B, Speiser W, Pabinger I, Lechner K, Eichinger S. Kyrle PA, et al. Among authors: weltermann a. Arterioscler Thromb Vasc Biol. 1998 Aug;18(8):1287-91. doi: 10.1161/01.atv.18.8.1287. Arterioscler Thromb Vasc Biol. 1998. PMID: 9714136 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page